Загрузка...
Reduced Mortality and Severe Disability Rates in the SENTIS Trial
BACKGROUND AND PURPOSE: The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of Neu...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Neuroradiology
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4156593/ https://ncbi.nlm.nih.gov/pubmed/23828106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3613 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|